373 related articles for article (PubMed ID: 20530204)
1. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.
Sander LE; Sackett SD; Dierssen U; Beraza N; Linke RP; Müller M; Blander JM; Tacke F; Trautwein C
J Exp Med; 2010 Jul; 207(7):1453-64. PubMed ID: 20530204
[TBL] [Abstract][Full Text] [Related]
2. Cell-autonomous hepatocyte-specific GP130 signaling is sufficient to trigger a robust innate immune response in mice.
Schumacher N; Yan K; Gandraß M; Müller M; Krisp C; Häsler R; Carambia A; Nofer JR; Bernardes JP; Khouja M; Thomsen I; Chalupsky K; Bolik J; Hölscher C; Wunderlich T; Herkel J; Rosenstiel P; Schramm C; Schlüter H; Renné T; Mittrücker HW; Rose-John S; Schmidt-Arras D
J Hepatol; 2021 Feb; 74(2):407-418. PubMed ID: 32987028
[TBL] [Abstract][Full Text] [Related]
3. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.
Fielding CA; McLoughlin RM; McLeod L; Colmont CS; Najdovska M; Grail D; Ernst M; Jones SA; Topley N; Jenkins BJ
J Immunol; 2008 Aug; 181(3):2189-95. PubMed ID: 18641358
[TBL] [Abstract][Full Text] [Related]
4. Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways.
Luchtefeld M; Preuss C; Rühle F; Bogalle EP; Sietmann A; Figura S; Müller W; Grote K; Schieffer B; Stoll M
PLoS One; 2011 May; 6(5):e19427. PubMed ID: 21573245
[TBL] [Abstract][Full Text] [Related]
5. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration.
Dierssen U; Beraza N; Lutz HH; Liedtke C; Ernst M; Wasmuth HE; Trautwein C
J Biol Chem; 2008 Apr; 283(15):9886-95. PubMed ID: 18216023
[TBL] [Abstract][Full Text] [Related]
7. Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.
Plum W; Tschaharganeh DF; Kroy DC; Corsten E; Erschfeld S; Dierssen U; Wasmuth H; Trautwein C; Streetz KL
Am J Pathol; 2010 May; 176(5):2236-46. PubMed ID: 20382701
[TBL] [Abstract][Full Text] [Related]
8. Myeloid cells require gp130 signaling for protective anti-inflammatory functions during sepsis.
Sackett SD; Otto T; Mohs A; Sander LE; Strauch S; Streetz KL; Kroy DC; Trautwein C
FASEB J; 2019 May; 33(5):6035-6044. PubMed ID: 30726111
[TBL] [Abstract][Full Text] [Related]
9. Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis.
Carow B; Reuschl AK; Gavier-Widén D; Jenkins BJ; Ernst M; Yoshimura A; Chambers BJ; Rottenberg ME
PLoS Pathog; 2013; 9(7):e1003442. PubMed ID: 23853585
[TBL] [Abstract][Full Text] [Related]
10. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.
Alkhateeb T; Kumbhare A; Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M
Mol Immunol; 2019 Aug; 112():72-81. PubMed ID: 31078118
[TBL] [Abstract][Full Text] [Related]
11. Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells.
Däbritz J; Judd LM; Chalinor HV; Menheniott TR; Giraud AS
Sci Rep; 2016 Feb; 6():20584. PubMed ID: 26848037
[TBL] [Abstract][Full Text] [Related]
12. Contribution of interleukin-6/gp 130 signaling in hepatocytes to the inflammatory response in mice infected with Streptococcus pyogenes.
Klein C; Medina E; Sander L; Dierssen U; Roskams T; Mueller W; Trautwein C; Goldmann O
J Infect Dis; 2007 Sep; 196(5):755-62. PubMed ID: 17674319
[TBL] [Abstract][Full Text] [Related]
13. Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation.
Giebeler A; Brandenburg LO; Kaldenbach M; Erschfeld S; Wasmuth H; Wruck C; Trautwein C; Streetz KL
Lab Invest; 2012 Dec; 92(12):1726-37. PubMed ID: 22986785
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response.
Brudecki L; Ferguson DA; McCall CE; El Gazzar M
Infect Immun; 2012 Jun; 80(6):2026-34. PubMed ID: 22451518
[TBL] [Abstract][Full Text] [Related]
15. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
16. The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury.
Diao W; Jin F; Wang B; Zhang CY; Chen J; Zen K; Li L
Protein Cell; 2014 Sep; 5(9):714-24. PubMed ID: 24981055
[TBL] [Abstract][Full Text] [Related]
17. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C
Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
Jones GW; McLeod L; Kennedy CL; Bozinovski S; Najdovska M; Jenkins BJ
Atherosclerosis; 2015 Feb; 238(2):321-8. PubMed ID: 25545330
[TBL] [Abstract][Full Text] [Related]
19. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling.
Greenhill CJ; Gould J; Ernst M; Jarnicki A; Hertzog PJ; Mansell A; Jenkins BJ
Immunol Cell Biol; 2012 May; 90(5):559-63. PubMed ID: 21670738
[TBL] [Abstract][Full Text] [Related]
20. Elevated CXCL1 expression in gp130-deficient endothelial cells impairs neutrophil migration in mice.
Yao L; Yago T; Shao B; Liu Z; Silasi-Mansat R; Setiadi H; Lupu F; McEver RP
Blood; 2013 Nov; 122(23):3832-42. PubMed ID: 24081661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
